Operating
Gain (Loss) on Investments
Edwards Lifesciences Gain (Loss) on Investments increased by 72.0% to -$3.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 72.0%, from -$12.50M to -$3.50M. Over 2 years (FY 2021 to FY 2023), Gain (Loss) on Investments shows a downward trend with a -94.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ1 2026May 6, 2026
How to read this metric
Positive values indicate successful investment management, while negative values reflect market volatility or poor asset selection.
Detailed definition
This reflects the realized gains or losses from the sale of investment assets, such as bonds or equities, held by the co...
Peer comparison
Common for insurance and financial firms with large investment portfolios.
Metric ID:
operating_gain_loss_on_investmentsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.20M | $9.20M | $9.20M | -$12.88M | -$12.88M | -$12.88M | -$12.88M | -$25.00K | -$25.00K | -$25.00K | -$25.00K | $1.00M | -$12.50M | -$3.50M |
| QoQ Change | — | +0.0% | +0.0% | -239.9% | +0.0% | +0.0% | +0.0% | +99.8% | +0.0% | +0.0% | +0.0% | >999% | <-999% | +72.0% |
| YoY Change | — | — | — | — | -239.9% | -239.9% | -239.9% | +99.8% | +99.8% | +99.8% | +99.8% | >999% | <-999% | +72.0% |
Range-$12.88M – $9.20M
CAGR-25.7%
Avg YoY Growth+250.1%
Median YoY Growth+85.9%
Gain (Loss) on Investments at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's gain (loss) on investments?
- Edwards Lifesciences (EW) reported gain (loss) on investments of -$3.50M in Q1 2026.
- How has Edwards Lifesciences's gain (loss) on investments changed year-over-year?
- Edwards Lifesciences's gain (loss) on investments increased by 72.0% year-over-year, from -$12.50M to -$3.50M.
- What is the long-term trend for Edwards Lifesciences's gain (loss) on investments?
- Over 2 years (2021 to 2023), Edwards Lifesciences's gain (loss) on investments has grown at a -94.8% compound annual growth rate (CAGR), from $36.80M to -$100.00K.
- What does gain (loss) on investments mean?
- The profit or loss realized from selling investment assets.